Clinical Trial Update: Genetic Studies in Difficult to Treat Asthma: TENOR

View source ↗

Summary

The TENOR study, a NHLBI-sponsored genetic investigation into difficult-to-treat asthma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Asthma, Lung Diseases | Status: COMPLETED